T1D is a chronic autoimmune disorder characterized by T-lymphocyte-mediated destruction of insulin-secreting pancreatic beta cells and results in the inability to regulate blood glucose levels.1 Over the past two decades, epidemiological studies conducted in the United States,2 Canada,3 China,4 the United Kingdom, and other European countries,5 have reported a steady increase in the prevalence of T1D. Here, INS is linked to type 1 diabetes mellitus.